Document Detail


Blood serum levels of proinflammatory cytokines in patients with different degrees of biliary pancreatitis.
MedLine Citation:
PMID:  17066155     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Proinflammatory cytokines play a fundamental role in the local and systemic inflammatory responses in the initial stages of acute biliary pancreatitis (ABP) and in the development of severe forms of the disease.
OBJECTIVES: The aim of the present study was to assess the systemic release of proinflammatory cytokines and to characterize differences between patients with mild ABP (MABP) and severe ABP (SABP).
PATIENTS AND METHODS: In the current study, 54 patients with MABP were compared with 14 patients with SABP. Serum levels of tumour necrosis factor-alpha, interleukin (IL)-1beta, IL-6, IL-8 and IL-12p40 were measured every second day after admission for one week.
RESULTS: The tumour necrosis factor-alpha level was similar in all days of analysis in patients with MABP but was lower compared with SABP patients. The level of IL-1beta was higher at admission in patients with MABP. The level of IL-6 peaked on admission day in both groups, but in patients with SABP, the obtained values were higher. The level of IL-8 on admission day was slightly higher in patients with MABP and systematically decreased when measured on the following days (the third, fifth and seventh days of the study). An increased level of IL-8 during the third, fifth and seventh days of the investigation was seen in SABP patients. The level of IL-12p40 was slightly higher in patients with MABP on the day of admission.
CONCLUSIONS: The levels of some proinflammatory cytokines are higher in patients with SABP than in patients with MABP. The most consistent difference between the two groups was that the levels of IL-6 were significantly higher in patients with SABP throughout the study. Serum concentration of IL-6 may be helpful as a marker of severity and outcome of ABP.
Authors:
Józefa Panek; Danuta Karcz; Rrichard Pieton; Jakub Zasada; Marcin Tusinski; Miroslaw Dolecki; Marek Winiarski
Related Documents :
3485575 - Release of interleukin-1 by peripheral blood mononuclear cells in patients with tubercu...
9428435 - C-reactive protein as a marker for tissue damage in patients undergoing eswl with or wi...
21062445 - Clinical aspects and cytokine response in severe h1n1 influenza a virus infection.
16691095 - Complex regional pain syndromes in children and adolescents: regional and systemic sign...
22843265 - Hexanucleotide repeat expansions in c9orf72 in the spectrum of motor neuron diseases.
1826125 - Atrial natriuretic peptide in dialysis patients under various conditions of volume home...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Canadian journal of gastroenterology = Journal canadien de gastroenterologie     Volume:  20     ISSN:  0835-7900     ISO Abbreviation:  Can. J. Gastroenterol.     Publication Date:  2006 Oct 
Date Detail:
Created Date:  2006-10-26     Completed Date:  2007-01-16     Revised Date:  2014-01-17    
Medline Journal Info:
Nlm Unique ID:  8807867     Medline TA:  Can J Gastroenterol     Country:  Canada    
Other Details:
Languages:  eng     Pagination:  645-8     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged, 80 and over
Cytokines / blood*
Female
Humans
Interleukin-12 Subunit p40 / blood
Interleukin-1beta / blood
Interleukin-6 / blood
Interleukin-8 / blood
Male
Middle Aged
Pancreatitis / blood*,  physiopathology
Severity of Illness Index
Tumor Necrosis Factor-alpha / blood
Chemical
Reg. No./Substance:
0/Cytokines; 0/Interleukin-12 Subunit p40; 0/Interleukin-1beta; 0/Interleukin-6; 0/Interleukin-8; 0/Tumor Necrosis Factor-alpha
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cardiovascular disease and diabetes mellitus: highlights from the Annual Professional Conference of ...
Next Document:  Antibiotic therapy for Crohn's disease: a review.